BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36448646)

  • 21. Laparoendoscopic single-site retroperitoneal lymph node dissection in non-seminomatous germ cell malignancy.
    Angulo JC; Redondo C; Gimbernat H; Ramón de Fata F; García-Tello A; García-Mediero JM
    Actas Urol Esp; 2015 May; 39(4):253-8. PubMed ID: 25438690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraperitoneal laparoscopic retroperitoneal lymph node dissection for early-stage testicular nonseminomatous germ cell tumors: initial experience.
    Qin C; Shao P; Meng X; Li P; Cao Q; Lv Q; Li J; Ju X; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    J Endourol; 2012 Sep; 26(9):1203-9. PubMed ID: 22524310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor.
    Kim P; Syan-Bhanvadia S; Djaladat H; Faber K; Tadros NN; Nichols C; Daneshmand S
    Urology; 2012 Oct; 80(4):941-5. PubMed ID: 22951007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours - a systematic review.
    Rosenvilde JJ; Pedersen GL; Bandak M; Lauritsen J; Kreiberg M; Wagner T; Aagaard M; Daugaard G
    Acta Oncol; 2021 Jun; 60(6):695-703. PubMed ID: 33819117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Retroperitoneal lymphadenectomy in testicular tumors].
    Mast GJ; Jung P; Moll V; Neisius D
    Chirurg; 1989 Mar; 60(3):148-52. PubMed ID: 2541979
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The assesment of significance of the retroperitoneal lymph node dissection in proximity of metastatic tumor with main vessels in patients with germ cell testicular tumors].
    Tereshin OS; Zotov SP; Vazhenin AV; Mamonova AO
    Vestn Khir Im I I Grek; 2013; 172(1):94-8. PubMed ID: 23808237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
    Kunit T; Janetschek G
    Urol Clin North Am; 2015 Aug; 42(3):321-9. PubMed ID: 26216819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified Retroperitoneoscope Retroperitoneal Lymph Node Dissection for a Non-seminomatous Testicular Tumor-a Video Vignette.
    Zhang J; Chen Y; Liang Y; Cao M
    Urology; 2022 Sep; 167():e8-e9. PubMed ID: 35688288
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.
    Arai Y; Kaiho Y; Yamada S; Saito H; Mitsuzuka K; Yamashita S; Namiki S; Nakagawa H; Ishidoya S; Ito A
    Int Urol Nephrol; 2012 Oct; 44(5):1389-95. PubMed ID: 22648291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of Retroperitoneal Lymph Node Dissection.
    Cary C; Foster RS; Masterson TA
    Urol Clin North Am; 2019 Aug; 46(3):429-437. PubMed ID: 31277737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Thor A; Grenabo Bergdahl A; Almås B; Håkansson U; Törnblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Sagstuen Haugnes H; Engen Andreassen K; Melsen Larsen S; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2022 Apr; 5(2):235-243. PubMed ID: 33750683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reduced retroperitoneal lymphadenectomy for clinical stage I non seminomatous germ cell testicular cancer].
    Valdevenito Sepúlveda JP; Merhe Nieva E; Valdevenito Sepúlveda R; Cuevas Toro M; Gómez Gallo A; Bermúdez Luna H; Contreras Meléndez L; Gallegos Méndez I; Gallardo Escobar J; Palma Ceppi C
    Arch Esp Urol; 2007 Apr; 60(3):245-54. PubMed ID: 17601299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
    Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
    World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.